Completed Heart, Stroke & Blood Genetics & Molecular Biology

Non-coding RNA in vascular pathophysiology (renewal)

In plain English

AI plain-English summary

When blood vessels are damaged—by surgery, stents, or disease—the inner lining can thicken abnormally, narrowing the passage and restricting blood flow. This process, called neointima formation, is a major clinical problem after procedures like angioplasty or bypass grafting. The researchers have already shown that small pieces of genetic material called microRNAs (miRNAs) play a key role in this thickening. Now they want to understand exactly how these molecules control the behaviour of the two main cell types in blood vessel walls: smooth muscle cells and endothelial cells. They will use genetically modified mice to track what happens when miRNA production is disrupted, and they will also investigate a related class of molecules called long non-coding RNAs (lncRNAs). This is fundamental science—it does not aim to produce a new treatment tomorrow. But understanding the molecular wiring that drives vessel narrowing could eventually point to new drug targets for preventing restenosis (re-narrowing after treatment) or for managing conditions like atherosclerosis. Similar fundamental work on non-coding RNA has already led to clinical trials for cancer and heart disease, so the translational potential here is real, if distant.

View original technical description
Vascular injury, induced by divergent stimuli, leads to neointima formation, a process involving complex interplay between multiple cell types that naturally reside in the vessel wall and those that infiltrate vascular tissue post-injury. The resulting endothelial dysfunction, vascular smooth muscle cell phenotype switching and inflammation lead to neointima formation, a scenario that remains a major clinical burden. Our recent work has highlighted the importance of non-coding RNA, particularly miRNA, in post-injury neointima formation. In this application, we will define at the molecular, cellular and whole animal levels the connectivity between non-coding RNA and vascular cell regulation and function. We will focus on miRNA biogenesis, including assessment of main and passenger strands of the miRNA stem loop, regulation of miRNA clusters and detailed analysis of the target pathways affected by miRNA dysregulation, including vascular smooth muscle and endothelial components of the response to injury in novel murine genetic models. We will also integrate additional studies to evaluate the expression, regulation and function of long non-coding RNA (lncRNA). Collectively, our programme of work will provide a detailed fundamental understanding of the regulation and role of non-coding RNA in vascular neointima formation as well as provide innovative approaches for future translation to the clinic.

View the original record at the funder ↗

Researchers

Andrew Howard Baker (EPMC Awardee)

Related Research

Grants with similar aims, by meaning.

Modelling the non-coding genome using RNA and CRISPRi/a approaches to define vascular heterogeneity in health and disease
Assessing the contribution of microRNA to in-stent restenosis (Dr Eilidh McGinnigle)
Extracellular vesicle-mediated delivery of long non-coding RNA: Implications for vascular repair and regeneration
Determining the regulatory pathways controlling venous and lymphatic vessel growth and their role during heart development and regeneration
Functional roles of hnRNPA1 in vascular smooth muscle cell phenotype modulation and neointima hyperplasia

Original classification

Programme Grant

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.